Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapartum Glucose and Insulin for Neonatal Hypoglycemia Prevention
NCT03273881Unknown
- Sponsor
- Emek Medical Center
- Start
- Oct 2017
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in Gestational Diabetes Mellitus (GDM) and diabetes mellitus (DM) (2 arms), sponsored by Emek Medical Center. Primary endpoint: Neonatal hypoglycemia. Status: unknown.
02
Drugs
human insulin
03
Conditions
Gestational Diabetes Mellitus (GDM)diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03273881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03273881.